Journal of Global Infectious Diseases
Cure8 research brief
Why This Matters
People with IBD and other immune-mediated inflammatory diseases may be at risk for lasting symptoms after COVID-19, and those symptoms were associated with worse quality of life in this study. Awareness can help clinicians and patients monitor and address persistent symptoms.
Who Should Pay Attention
Adults with IBD and other IMIDs, caregivers, clinicians, and researchers focused on post-COVID-19 outcomes.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This study screened adults with immune-mediated inflammatory diseases (IMIDs) — mainly IBD and rheumatic diseases — at a university outpatient clinic for prior COVID-19 and persistent symptoms. About half reported prior COVID-19; among those, roughly one-quarter met the WHO definition of post-COVID-19 condition (symptoms ≥3 months).
Patients with post-COVID-19 had lower average quality-of-life scores on validated patient-reported measures compared with those without. The report is based on a questionnaire-based cross-sectional sample (156 patients total, 117 with IBD). Most COVID-19 cases were mild and rare hospitalizations were reported.
Quality-of-life was measured with Short IBD Questionnaire and EQ-5D-5L; the authors report a statistically significant association between post-COVID-19 status and lower QoL (P = 0.03). Limitations to
Keep In Mind
Abstract-level clinical study from a single university outpatient center with questionnaire-based data; findings indicate association but cannot establish causation. The abstract lacks detailed subgroup analyses and treatment-stratified results.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationJournal of Global Infectious Diseases
AuthorsTobias Schlosser, Marco Krasselt, Martin Hecker +2 more
InstitutionUniversity Hospital Leipzig
Study typeArticle
Indexed viaOpenAlex
Source typeResearch paper
PublishedAug 10, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Hidradenitis Suppurativa More Prevalent Among Patients With Crohn Disease
Skin disease (hidradenitis suppurativa) may be more common in people with IBD—particularly Crohn disease—and could be linked with more severe intestinal complications. Awareness can prompt coordinated care between...
Metabolic Syndrome in Inflammatory Bowel Disease: Prevalence, Risk Factors, and Impact on Disease Outcomes in a North African Cohort
Metabolic syndrome appears common in this Tunisian IBD cohort (about one-third). MetS can affect overall health and may influence long-term outcomes for people with IBD, so awareness and cardiometabolic screening may be...
Cardiac structure and function in patients with inflammatory bowel disease.
A pooled analysis found modest differences in cardiac structure and function in people with IBD versus controls, which may relate to the higher cardiovascular risk seen in this population.